|
3M submitted several assay validation and sample analysis reports to the EPA regarding the quantitative determination of PFOS and related compounds in human serum, as part of their ongoing dialogue about fluorochemicals.
|
2003 |
AR226-1207
|
6R5LEg1JygYeeeQe7wZY7mONd |
2 |
|
The Society of the Plastics Industry, Inc. submitted a guidance document to the EPA on detecting and quantifying low levels of fluoropolymer polymerization aids, intended to provide general guidelines based on industry experience.
|
2003 |
AR226-1215
|
vR6pyROqjNapb191xk63pExZ |
20 |
|
The document reports on a pharmacokinetic study of potassium perfluorohexanesulfonate in cynomolgus monkeys, detailing the serum and urinary excretion patterns following a single intravenous dose, with findings indicating significant differences in serum concentrations over time between male and female subjects.
|
2003 |
AR226-1361
|
e7J3w1oM3xgZKav6vjOMjGJq4 |
51 |
|
This document reports on a pharmacokinetic study of potassium perfluorooctanoate (PFOA) in cynomolgus monkeys, detailing the serum and urinary excretion patterns following a 10 mg/kg intravenous dose, with findings indicating differences in serum concentration decline rates between male and female monkeys over a 123-day period.
|
2003 |
AR226-1362
|
MG7oOQmweVR08oG4YK2gL2r5z |
61 |
|
The document is a final report from the University of Dayton Research Institute detailing the laboratory-scale thermal degradation of Perfluoro-Octanyl Sulfonate (PFOS) and related substances, conducted under the direction of 3M Environmental Lab between March 2001 and December 2002.
|
2003 |
AR226-1367
|
jB2gN9dpnN9wjK7MG3082o3jN |
159 |
|
The document reports on a toxicity study of perfluorooctanesulfonate (PFOS) conducted on various terrestrial plant species, using a sample from 3M with a purity of 86.9%, following U.S. EPA and OECD guidelines to assess the effects on plant emergence, survival, weight, and height.
|
2003 |
AR226-1368
|
ev2VY83ZDYaqLzjJDkxaeNOoq |
12 |
|
The document is a submission from Bob Buck of DuPont to the EPA, providing study reports related to 8-2 Telomer B Alcohol (CAS# 678-39-7) for inclusion in Administrative Record 226, detailing various OECD studies on its environmental impact.
|
2003 |
AR226-1217
|
km32rQ6JZDreKwBz8EJ2ZGyjV |
2 |
|
The Telomer Research Program submitted final reports to the U.S. EPA on the acute aquatic toxicity of 8-2 Telomer B Alcohol, indicating it poses low to medium concern for acute effects on aquatic species based on testing conducted according to OECD guidelines.
|
2003 |
AR226-1218
|
dDDMBB5dqg1d3R7D5k9KdGdM9 |
40 |
|
The document discusses the submission of final reports on the acute aquatic toxicity of 8-2 Telomer B Alcohol (CAS No. 678-39-7) by the Telomer Research Program and its member companies to the U.S. EPA, indicating that the substance poses low to medium concern for acute effects on aquatic species based on testing conducted according to OECD guidelines.
|
2003 |
AR226-1219
|
4vOarxJRvQXJQ99pRmDQqzrBp |
40 |
|
This document is a submission from DuPont to the EPA, providing study reports on 8-2 Telomer B Alcohol (CAS# 678-39-7) for inclusion in Administrative Record 226, detailing OECD 202 Acute Daphnia studies.
|
2003 |
AR226-1221
|
1g9Ry168Q02vqXoyzKwnbemmK |
2 |
|
The document is a correspondence from the Telomer Research Program, including Clariant and other member companies, to the EPA, providing final reports on the acute aquatic toxicity of 8-2 Telomer B Alcohol (CAS No. 678-39-7), indicating it poses low to medium concern for acute effects on aquatic species based on testing conducted according to OECD guidelines.
|
2003 |
AR226-1222
|
EqjK61O7b3MQ2KBEEQoBYvb2n |
32 |
|
The document is a letter from Taft, Stettinius & Hollister LLP to the EPA regarding TSCA Section 8(e) reporting for PFOA, specifically addressing contamination from E.I. duPont de Nemours and Company's fluoropolymer manufacturing facility affecting local drinking water.
|
2003 |
AR226-1372
|
wKzxoXD24ymEjdK1L3MKj9yxJ |
15 |
|
The document is a letter from a former DuPont employee to EPA Administrator Christine Whitman, alleging that DuPont has engaged in cover-ups and violations related to the environmental release and disposal of PFOA (C8), expressing concerns for public health and safety.
|
2003 |
AR226-1692
|
2NzaG8b9BkKORmao6ZzeX81Qg |
2 |
|
The Weinberg Group Inc. is preparing to advise DuPont on managing issues related to perfluorooctanoic acid (PFOA) and aims to shape the debate to prevent further regulatory and legal challenges regarding environmental concerns associated with PFOA.
|
2003 |
AR226-1693
|
YGQ1Bn35VOE5G7D4yMbeNRJ00 |
5 |
|
DuPont submitted drinking water monitoring data related to PFOA to the EPA, clarifying that the data does not trigger reporting obligations under Section 8(e) of the Toxic Substances Control Act, while providing it for the EPA's regulatory considerations.
|
2003 |
AR226-1408
|
9Jg7LjjE8ZwnkmXrBjLK9856e |
4 |
|
The document presents the results of a sampling investigation conducted by DuPont and URS at the Little Hocking Water Association well field in Washington County, Ohio, focusing on the presence of PFOA (C-8) in groundwater and soil samples.
|
2003 |
AR226-1416
|
g2N5BnjRem6zEOVwYjzN6RDbJ |
83 |
|
The document is a letter from the Telomer Research Program, including companies like Clariant and DuPont, to the EPA, providing final reports on the acute aquatic toxicity of 8-2 Telomer B Alcohol, indicating it poses low to medium concern for acute effects on aquatic species based on testing conducted according to OECD guidelines.
|
2003 |
AR226-1223
|
37Q6Z2nDgKwkgGmRneDdVpXqx |
30 |
|
The document is a submission from DuPont on behalf of the Telomer Research Program, providing study reports on 8-2 Telomer B Alcohol (CAS# 678-39-7) for inclusion in the EPA's Administrative Record 226, detailing OECD 203 acute fish studies.
|
2003 |
AR226-1224
|
JR1wq98NezzgEgdrJ6OQ90re |
2 |
|
The document discusses the submission of final reports to the U.S. EPA by the Telomer Research Program, including member companies Asahi Glass, Clariant, Daikin, and DuPont, regarding the acute aquatic toxicity testing of 8-2 Telomer B Alcohol, indicating it poses low to medium concern for acute effects on aquatic species.
|
2003 |
AR226-1225
|
jma3Jg18g2xbyLZVRpgEq1MDk |
33 |
|
3M submitted a final report on a pharmacokinetic study of potassium perfluorooctanoate to the EPA as part of their ongoing dialogue regarding perfluorinated compounds.
|
2003 |
AR226-1227
|
Md7pY4OYqag64K3Z8avx58aL |
1 |
|
The document is a letter from Clariant to the EPA reporting on the acute aquatic toxicity testing of 8-2 Telomer B Alcohol, indicating that the substance is of low to medium concern for acute effects on aquatic species based on the results of studies conducted according to OECD guidelines.
|
2003 |
AR226-1226
|
o35b7jNOngjxrbRVmMz0a64R |
33 |
|
This document reports on a pharmacokinetic study of potassium perfluorooctanoate (PFOA) in cynomolgus monkeys, detailing the serum and urinary excretion patterns following a single intravenous dose, with findings indicating gender differences in serum concentration decline over time.
|
2003 |
AR226-1228
|
6RaZVBn0B5VBE1jR7ggQEwaL6 |
60 |
|
The document discusses the APFN Work Group's evaluation of APFN (a perfluoroalkyl carboxylate surfactant) in relation to PFOA, highlighting its use in fluoropolymer production and the group's commitment to reducing emissions by 50% from 1999 or 2000 levels.
|
2003 |
AR226-1229
|
J30OvLJdK363X0Vr6z80w7p2v |
18 |
|
This is a letter from Asahi Glass Co., Ltd. dated March 19, 2003, discussing two products related to a polymer and indicating the presence of both confidential business information and sanitized versions for review.
|
2003 |
AR226-1230
|
ymmx0gqk0KREzO92Rz51Ryyqd |
2 |
|
Daikin Ltd. and Daikin America submitted a presentation to the EPA's Office of Pollution Prevention and Toxics on March 13, 2003, which included confidential information regarding fluoropolymer chemicals and corrections to a previously provided CAS number.
|
2003 |
AR226-1231
|
bByE1zYV1ZJnRpmq2g3qBBRQo |
25 |
|
The document reports on the quarterly sampling results of C-8 (PFOA) concentrations in public water supplies along the Ohio River, specifically from Little Hocking, Ohio, Lubeck, West Virginia, and Tuppers Plains, Ohio, as mandated by a Consent Order.
|
2003 |
AR226-1417
|
G7n6exdnn2v0go2geNV1bVex |
6 |
|
The document is a request for comments and solicitation of interested parties by the EPA regarding potential human health concerns about Perfluorooctanoic Acid (PFOA) as part of the development of enforceable consent agreements for additional data collection.
|
2003 |
AR226-1418
|
OznY4QR4q0z4wX5enOBrNZXaj |
1 |
|
The document is a submission from Katie Smythe on behalf of the Telomer Research Program, detailing study summaries on the acute hazard of 8-2 Telomer B Alcohol (C8F17CH2CH2OH) for inclusion in the EPA's Administrative Record 226, which includes findings from tests conducted on various freshwater aquatic species.
|
2003 |
AR226-1419
|
K6j8ZDY8eQ6Bpv2MeaLnzow2Q |
1 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium to assess the growth inhibition effects of a saturated solution of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- on the freshwater alga Sc
|
2003 |
AR226-1420
|
6w0Bz0VewNR7XjekDyqYLj5e6 |
2 |
|
The report details a study conducted by Dr. U. Noack-Laboratorium to assess the growth inhibition effects of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- on the freshwater alga Scenedesmus subsp
|
2003 |
AR226-1421
|
MJN6pp8qxyRKe2VZMmqKE9jRL |
2 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium to determine the acute toxicity of a saturated solution of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- to Daphnia magna, finding
|
2003 |
AR226-1422
|
nNQLEZZQy7qQNp6kbOp0n9GR1 |
2 |
|
This document reports on a study conducted by Dr. U. Noack-Laboratorium to determine the acute toxicity of the water accommodated fraction of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- to Daphnia magna,
|
2003 |
AR226-1423
|
jm1X2v2pZ5wnq0rnM6gqNegn2 |
2 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium to determine the acute toxicity of the water accommodated fraction of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- to zebrafish over a
|
2003 |
AR226-1425
|
2Rv7Vbxz88ZKpr74OppVb7p97 |
2 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium that assessed the respiration inhibition effects of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- on activated sludge, finding that the inhibition ranged from
|
2003 |
AR226-1426
|
re9ykykyx7LGGX2Ler0Kdgrq0 |
2 |
|
The document is a submission of study reports related to 8-2 Telomer B Alcohol (CAS# 678-39-7) from the Telomer Research Program, including toxicity tests on earthworms, nematodes, and terrestrial plants, to the EPA for inclusion in Administrative Record 226.
|
2003 |
AR226-1427
|
J8XrJ7qVad2daznYrQRxdEO6 |
1 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium that assessed the acute toxicity of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- on the earthworm species Eisenia fetida in artificial
|
2003 |
AR226-1428
|
3eyGDDJQqOgv6xLJo43EJmrEE |
2 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium to assess the effects of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- on the development of the nematode Caenorhab
|
2003 |
AR226-1430
|
GmdROrgykeeDEKmN0GyQZvpxN |
2 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium to assess the toxicity of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- on the seedling emergence and early growth stages of three terrestrial
|
2003 |
AR226-1432
|
KRRmNye3deNL2OR3Edxv19w6N |
2 |
|
DuPont submitted a comprehensive C-8 Data Summary Report to the West Virginia Department of Environmental Protection detailing the results of investigations and sampling related to perfluorooctanoic acid (C-8) at the Washington Works facility and associated landfills, including exposure assessments and comparisons to established screening levels.
|
2003 |
AR226-1415
|
rB4p47EzmDD8Ed0adXL5z02Rr |
288 |
|
The document is an analytical report from Exygen Research detailing the fluorochemical characterization of water and sediment samples from Decatur Bakers Creek #2, specifically analyzing for perfluorooctanoic acid (PFOA), perfluorooctanesulfonate (PFOS), and other fluorochemicals using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
2003 |
AR226-1701
|
jmb3NvKzqEm484gd6M25Xd5xp |
465 |
|
This document is a letter from Robert A. Bilott to Richard H. Hefter at the EPA, providing a C-8 blood model developed by DuPont related to estimated levels of perfluorooctanoate (PFOA) concentrations in the blood of communities exposed to DuPont's emissions.
|
2003 |
AR226-1477
|
LxXRMeJOakm3qM34rza7NO2g |
1 |
|
The final report from 3M Company details a descriptive analysis of serum concentrations of perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) among Antwerp employees, revealing that PFOA levels ranged from 0.92 to 5.69 ppm with two participants exceeding the company's biological limit value of 5 ppm, while PF
|
2003 |
AR226-1719
|
Eq1KqKQgLanbgoaZw8YpMZMZb |
16 |
|
This is a letterhead cover page from Clariant, with no analytical content retained in the OCR.
|
2003 |
AR226-1247
|
zboZY2Y93G550o34ve1N7wL9g |
1 |
|
The document is a submission from DuPont detailing information about their polymeric products related to the Telomer Research Program, including sales volumes and chemical identifiers, in compliance with a commitment to the EPA regarding perfluorinated compounds.
|
2003 |
AR226-1259
|
B6VVNmYqLM1qBRywNgeMboDX |
2 |
|
The document is a submission from DuPont regarding their Telomer Research Program, providing industrial hygiene air monitoring data and employee blood monitoring results related to PFOA from telomer manufacturing operations, in compliance with a voluntary commitment to the EPA.
|
2003 |
AR226-1258
|
mpjbMRx9Ndbk1Z4zG4awD0m8B |
6 |
|
This document is a letter from DuPont's Stephen H. Korzeniowski to the EPA's Mary Dominiak, providing information about DuPont's manufacturing locations for telomer-based products in the U.S. as part of the Telomer Research Program related to the potential release of PFOA.
|
2003 |
AR226-1260
|
44Lg3NzMy4qmBG3B2Ry0Y45M1 |
1 |
|
The document is a letter from DuPont's Stephen H. Korzeniowski to EPA's Mary Dominiak, providing information on biodegradation screening and method development studies related to the 8-2 Telomer Alcohol product as part of the Telomer Research Program.
|
2003 |
AR226-1261
|
1QzbdazYqvzbqboxvobj296ka |
1 |
|
The document summarizes the screening studies for the biodegradability assessment of 8-2 Telomer B Alcohol, focusing on the challenges of low water solubility and adsorption, with the aim of identifying critical parameters before conducting longer-term biodegradability studies to determine transformation products.
|
2003 |
AR226-1262
|
1QEpDG8kbe062JY7omjojr5gK |
3 |
|
This document is a submission of groundwater and wastewater monitoring data related to perfluorooctanoic acid (PFOA) from 3M's manufacturing sites in Cottage Grove, MN, and Decatur, AL, as required by the Letters of Intent issued by the EPA, detailing ongoing monitoring efforts following the phase-out of PFOA production.
|
2003 |
AR226-1482
|
nmDzN2Jdz9krZK1kEbBoDM69z |
12 |
|
This is a map detailing monitoring points for the 3M Cottage Grove facility, including new monitoring wells, production wells, and other sampling points, with a scale of 1:12,000.
|
2003 |
AR226-1483
|
yr8y28G478ayNwNVZO1nyZDXD |
1 |
|
3M submitted an electronic copy of its "Environmental and Health Assessment of Perfluorooctane Sulfonic Acid and its Salts" to the EPA, which integrates available data regarding PFOS.
|
2003 |
AR226-1485
|
pY5JQezZ9pn668rGvdLQdjLB |
1 |
|
The document outlines various studies on the kinetics of PFOA (perfluorooctanoic acid) in rats, including inhalation exposure, lactational transport to offspring, placental transfer from mother to fetus, and the effect of age on PFOA elimination, with data and reports expected between August and December 2003.
|
2003 |
AR226-1489
|
k6gjo7XX0qn2ovG4BopKnZ94J |
5 |
|
This document is a letter from Taft, Stettinius & Hollister LLP addressing the U.S. Environmental Protection Agency regarding human health threats from releases of PFOA/APFO/C-8 in West Virginia and Ohio, serving as a supplement to previous correspondence on the matter.
|
2003 |
AR226-1493
|
XzOYEpaee0E0r0v526bEEBgxJ |
2 |
|
This document is a follow-up letter addressing the potential human health threat from releases of PFOA (perfluorooctanoic acid) from the E.I. duPont Washington Works plant in West Virginia and Ohio.
|
2003 |
AR226-1495
|
Ra917ko5G5JVDDg35Lwqzj8Y7 |
2 |
|
The document is a cover letter from Gary W. Jepson of DuPont, enclosing a report on the toxicokinetics of perfluorooctanoic acid (PFOA) in rats, sponsored by the Association of Plastics Manufacturers of Europe Fluoropolymers Committee, addressed to Dr. Oscar Hernandez at the EPA.
|
2003 |
AR226-1498
|
re06o95N5ogv5kbbKGoBnZBgv |
1 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, submitting various documents related to PFOA/C-8 for inclusion in Administrative Record 226, including reports and letters concerning DuPont's air emissions and environmental impact.
|
2003 |
AR226-1500
|
06RxnpL2qwOp6rgkO1N746jyb |
2 |
|
The Ohio EPA expresses concerns regarding air impacts from ammonium perfluorooctanoate (C8) emissions from DuPont's Washington Works facility, highlighting modeled ambient concentrations exceeding health-based workplace standards and ongoing evaluations of C8's toxicity.
|
2003 |
AR226-1502
|
nm4Kkz4v2nxE9xarng1DNKwwR |
2 |
|
The document is a letter to Governor Bob Wise expressing concerns about potential conflicts of interest within the West Virginia Department of Environmental Protection regarding the review of toxic Teflon production catalyst (PFOA) in drinking water, and requests the establishment of an independent panel to address scientific questions related to its safety.
|
2003 |
AR226-1504
|
OErwaEv0mkkv15x5jnN7YE0BX |
3 |
|
The West Virginia Department of Environmental Protection notified DuPont Washington Works of a provisional air screening level of 1.0 microgram per cubic meter for ammonium perfluorooctanoate (PFOA), requiring compliance to limit emissions in public-access areas.
|
2003 |
AR226-1505
|
K2LxQoMVL1G3v6dDJz29v0QK |
3 |
|
The document is a policy memo from the Environmental Working Group addressing DuPont's failure to submit key health studies related to PFOA (perfluorooctanoic acid) as required by the Toxic Substances Control Act, urging the EPA to investigate and impose penalties for these violations.
|
2003 |
AR226-1507
|
2jnd0zZzDqyOpOKxMKp4DYLQg |
2 |
|
The document is a surface water monitoring report from February 2003 for the Washington Works Facility and local landfills in West Virginia, focusing on the analysis of C-8 (PFOA) concentrations in surface water samples.
|
2003 |
AR226-1508
|
x10k2jZYgn5jkxEQLnyLvmLG0 |
56 |
|
The document is an environmental and health assessment of perfluorooctane sulfonic acid (PFOS) and its salts, prepared by 3M in consultation with various experts, covering topics such as analytical methodology, environmental risk assessment, and human health risk assessment.
|
2003 |
AR226-1486
|
jmqy5B512ObRYybM2B5vdkVgZ |
638 |
|
The document details a study conducted by Exygen Research, sponsored by 3M Environmental Technology and Safety Services, focused on the extraction of potassium perfluorooctanesulfonate (PFOS) from red blood cells and serum for analysis using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with Good Laboratory Practice standards.
|
2003 |
AR226-1744
|
O3YaKrQnMdB9L3V9718jxEYnv |
98 |
|
3M submitted an electronic copy of its "Environmental and Health Assessment of Perfluorooctane Sulfonic Acid and its Salts" to the EPA, which integrates available data regarding PFOS.
|
2003 |
AR226-1781
|
k6EyBVg6DbrO8GezrrQkQz0EO |
1 |
|
This document is a revised report by Mark E. Ellefson from the 3M Environmental Laboratory detailing the analysis of samples from the Tennessee River Valley, specifically focusing on perfluorinated compounds.
|
2003 |
AR226-1733
|
zd9mrpMG43zyv8M4z9aGLnYaz |
276 |
|
3M submitted information to the EPA regarding perfluorooctane sulfonates and related compounds, including a pharmacokinetic study of potassium perfluorooctanoate in cynomolgus monkeys, as part of their ongoing dialogue about fluorochemicals.
|
2003 |
AR226-1781
|
v6R9EkVDoENNjDnnZwRg9pbaE |
1 |
|
The document is an environmental and health assessment of perfluorooctane sulfonic acid (PFOS) and its salts, prepared by 3M in consultation with various experts, focusing on ecological risk, human health risk, and exposure data.
|
2003 |
AR226-1486
|
MG41y25p5VzG4YqQdjBgYpBoy |
638 |
|
The document presents the results of a sampling investigation conducted by DuPont and URS Diamond on groundwater and soil for perfluorooctanoic acid (C-8, a precursor to PFOA) in the Little Hocking Water Association well field in Washington County, Ohio, in April 2003.
|
2003 |
AR226-1509
|
qm8KD6KXXOx0oxGvZgp2wBEK5 |
86 |
|
The document is an order from the Circuit Court of Wood County, West Virginia, granting injunctive relief against DuPont for the contamination of drinking water with ammonium perfluorooctanoate (PFOA), which is found to be toxic and biopersistent in humans.
|
2003 |
AR226-1510
|
Vxk81kLRE1dEDp6y0D93rj6Z |
9 |
|
The document is an order from the Circuit Court of Wood County, West Virginia, granting Plaintiffs' Second Motion for Sanctions against E. I. du Pont de Nemours and Company for failing to comply with court orders regarding the production of documents related to PFOA (C-8) issues.
|
2003 |
AR226-1511
|
ZBkV9poXXXB2LX1Lg42v1od8p |
3 |
|
3M is submitting additional data and studies on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), and related compounds to the EPA as part of their ongoing dialogue regarding perfluorochemicals, including a redacted Protein Binding Study report and a bibliography of recent literature.
|
2003 |
AR226-1512
|
NB6Dwg5k0ZykLegqa4E8pqDy |
9 |
|
DuPont submitted a progress report to the EPA on September 15, 2003, detailing its environmental assessments of air and water levels of APFO around its Washington Works facility, including extensive ground and surface water sampling and analyses.
|
2003 |
AR226-1516
|
vbMzZzR3YD952KKm9bM5B598 |
4 |
|
The document discusses the fluorosurfactants used by Ansul Corp. in the production of Military Specification AFFF, confirming that perfluoro chains were present in the products supplied during the 1980s.
|
2003 |
AR226-1518
|
evEJ3jJKLkbwwJpK2eG25844G |
1 |
|
The document is a submission from the Telomer Research Program, representing companies including Asahi Glass, Clariant, Daikin, and DuPont, to the EPA, providing a study report on the atmospheric fate of fluorinated alcohols for inclusion in the administrative record on PFOA/PFOS.
|
2003 |
AR226-1519
|
gz2ODkmwBYEwpkg9bXj29a7a |
1 |
|
The report details a study on the atmospheric fate of fluorinated alcohols, specifically focusing on the reaction kinetics of trifluoropropanol (TFP) and tridecafluoro-octanol (TDO) with hydroxyl radicals, revealing their rate constants at room temperature as part of a broader investigation into the behavior of 2-perfluoro-n-octyl ethanol (2PO
|
2003 |
AR226-1521
|
RjNOb1LN5QQ54y0k2EO3gwOkk |
29 |
|
The document is the August 2003 report from the Ammonium Perfluorooctanoate (C-8) Groundwater Investigation Steering Team, detailing findings and actions related to groundwater contamination from PFOA in West Virginia and Ohio, as part of Consent Order No. GW-2001-019.
|
2003 |
AR226-1517
|
j1E3BEZgYwXdeyQ2bN7y0vyy |
147 |
|
The document is a final report on a combined repeated dose toxicity study of the test substance T-7706, which includes reproduction and developmental toxicity screening, conducted on male and female rats, with results detailing various health metrics and observations.
|
2003 |
AR226-1730
|
oD81D3yjGQBBnrMJz7a38Yr |
771 |
|
3M submitted a final report on an oral combined repeated dose toxicity study with reproductive/developmental toxicity screening test for perfluorohexane sulfonate potassium salt (PFHS) to the EPA, confirming previously reported preliminary results.
|
2003 |
AR226-1522
|
pp6ENbKogyR6XVv3KvVwyXega |
2 |
|
This document is a supplemental submission from 3M to the EPA regarding the final report of a 28-day oral toxicity study in rats for the substance 1-Butanesulfonylfluoride, 1,1,2,2,3,3,4,4-octafluoro-4-[(trifluoroethenyl)oxy] (CAS:
|
2003 |
AR226-1524
|
By8yg8bjd8rjQQBNxkJ3GK1ak |
1 |
|
3M submitted a final report on a toxicity study of perfluorooctanesulfonate (PFOS) to the EPA, confirming results consistent with previously reported information.
|
2003 |
AR226-1526
|
NGzawvQReE5EvLBwB1D8rxQo8 |
1 |
|
The email expresses outrage over the EPA's postponement of the final risk assessment for PFOA due to an industry study, arguing that PFOA poses significant risks and criticizing industry tactics that delay regulatory action while profiting from continued sales.
|
2003 |
AR226-1528
|
m3Ey51NZjVmOReKy2M30jyq4 |
2 |
|
The document discusses the persistence of fluorotelomer alcohols (FTOHs) in the atmosphere, highlighting research by scientists from Ford Motor Co. and the University of Toronto that indicates these compounds can persist for 20 days before breaking down, raising concerns about their potential toxicity and the need for further study on their environmental impact.
|
2003 |
AR226-1529
|
a4voXNq9Qg5Xw9X2YvovM0zdY |
2 |
|
This document discusses the atmospheric lifetime and reactivity of fluorotelomer alcohols, specifically noting that the atmospheric lifetime of these compounds is primarily determined by their reaction with hydroxyl radicals, while also highlighting the persistence and bioaccumulation of PFOS as a contaminant.
|
2003 |
AR226-1530
|
o9YanJyg0dXo15RdYDjD7gj27 |
5 |
|
This study investigates the bioconcentration and tissue distribution of perfluorinated acids (PFAs) in rainbow trout, revealing that PFAs accumulate primarily in blood, kidney, and liver, with bioconcentration factors increasing significantly with longer perfluoroalkyl chain lengths.
|
2003 |
AR226-1531
|
4vwxZoqBzp07epYpDn4GpZ4BQ |
9 |
|
The document is a cover letter from Ann K. Masse of DuPont, submitting a report titled "DuPont Telomer Manufacturing Sites: Environmental Assessment of PFOA Levels in Air and Water" to the EPA, which addresses PFOA levels related to DuPont's manufacturing operations in West Virginia and New Jersey.
|
2003 |
AR226-1533
|
jg5E8kEVqXQEn11owMqG6jxOR |
1 |
|
The document discusses the cumulative risk assessment of perfluorinated acids, specifically PFOS and PFOA, highlighting their common mechanism of toxicity related to the uncoupling of oxidative phosphorylation and its implications for human health.
|
2003 |
AR226-1532
|
5LM07JjZvgBBKD5dgbvdEvw4z |
35 |
|
This letter from DuPont provides additional information regarding the active ingredient in Zonyl FSP Fluorosurfactant, which contains perfluorinated compounds used in cleaning products, and includes guidance on safe use and disposal procedures.
|
2003 |
AR226-1535
|
aJZEXeVXnev78x30oonQ1R85y |
1 |
|
The DuPont Material Safety Data Sheet for "ZONYL" FSP Fluorosurfactant outlines its composition, potential health hazards, and emergency contact information, indicating that exposure may cause eye irritation and respiratory issues, particularly due to its isopropyl alcohol content.
|
2003 |
AR226-1536
|
BNMg79x3vLbVQEzkm1ozKaqk |
8 |
|
DuPont submitted a follow-up report to the EPA detailing air dispersion modeling results for PFOA emissions from its Washington Works facility, indicating a reduction in emissions from 2002 to 2003 due to the installation of a new secondary recovery scrubber.
|
2003 |
AR226-1538
|
adOJQo91vO9Ymw42xMx1084Y |
3 |
|
The document is an environmental assessment report by DuPont on PFOA levels in air and water at their Telomer Manufacturing Sites, detailing data analysis, air dispersion modeling, and groundwater sampling.
|
2003 |
AR226-1534
|
LJd65Env4gyjx5x15Ge26gR5w |
70 |
|
3M submitted a TSCA Section 8(e) substantial risk notice to the EPA regarding preliminary findings from a toxicity study on 1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-n-methyl (N-MePFBA), indicating significant reproductive effects and possible neurotoxicity in rats at high dosage
|
2003 |
AR226-1541
|
gDeNLRBwdeoKgwoXwaQ66G3O3 |
2 |
|
This document is a toxicology study report (PT02-0222) conducted by Aventis Pharma on the oral toxicity of a substance related to PFOA over a 28-day period with a subsequent 14-day recovery phase.
|
2003 |
AR226-1525
|
gay4BB67EZV26r5M7ODnY411J |
496 |
|
This document reports on a combined repeated dose toxicity study with reproduction and developmental toxicity screening for the substance T-7601 (PFOA) administered by oral gavage in Wistar rats, noting treatment-related clinical signs and mortality in the high dose group (1000 mg/kg).
|
2003 |
AR226-1542
|
zz37VOkB6J6XZOv1b91LMM7DB |
7 |
|
The document discusses an update on cancer incidence and overall mortality rates among employees and pensioners of E. I. du Pont de Nemours and Company, emphasizing the need for careful interpretation of the data in relation to employee health monitoring, but does not specifically mention PFOA or PFOS.
|
2003 |
AR226-1545
|
Evg91qVd9K6YV05eNKN04pkRn |
11 |
|
The document provides cancer incidence and mortality surveillance data for Du Pont employees at the Washington Works site from 1956-1989 and 1957-1991, respectively, generated from the company's epidemiologic surveillance program, with a recommendation for further follow-up if statistically significant excesses are found.
|
2003 |
AR226-1546
|
JNJN3KZxkJ9NjEaL41XK2B2Na |
9 |
|
The document reports on a study conducted by E.I. du Pont de Nemours and Company examining the age effect on plasma concentration of Ammonium Perfluorooctanoate in post-weaning rats following oral gavage, completed on December 15, 2003.
|
2003 |
AR226-1553
|
bBoakZzLQ9O85zwkKjdmYY0xZ |
34 |
|
This document details a pharmacokinetic study on PFOA conducted by E.I. du Pont de Nemours and Company and 3M Company, focusing on the lactational and placental transport of PFOA in rats, completed on December 19, 2003, and compliant with Good Laboratory Practice standards.
|
2003 |
AR226-1551
|
n9XQQ9zGBRBNnq1ZDge825MpG |
143 |
|
3M submitted a series of assay validation and analysis reports to the EPA regarding the quantitative determination of perfluorooctane sulfonate (PFOS) and related compounds in human serum, as part of their ongoing dialogue about fluorochemicals.
|
2003 |
AR226-1781
|
1QOa7yGe6Drmkzodd164OOQKj |
2 |
|
The document is a final report on an oral gavage combined repeated dose toxicity study of the test substance T-7706, which includes reproductive and developmental toxicity screening, conducted on male and female rats.
|
2003 |
AR226-1523
|
oDEL11ZE9J3Y6LodJ4grwN6Er |
769 |
|
This is a letter from a medical director regarding a PFOA/PFOS-related inquiry, dated January 27, 2003, with no analytical content retained in the OCR.
|
2003 |
AR226-1781
|
wrGqwqR2NyBzgemQ5nkRXNRy6 |
1 |